TY - JOUR AU - Baldwin, A. Lane AU - Cook-Deegan, Robert PY - 2013 DA - 2013/01/31 TI - Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin® JO - Genome Medicine SP - 8 VL - 5 IS - 1 AB - The development of Herceptin® is welcomed as a major advance in breast cancer treatment, while Myriad's development of BRACAnalysis® is a widely used diagnostic. However useful and successful this product is, its presence in the public eye is tainted by predominantly negative press about gene patenting and business practices. SN - 1756-994X UR - https://doi.org/10.1186/gm412 DO - 10.1186/gm412 ID - Baldwin2013 ER -